DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients With Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
2 other identifiers
interventional
400
29 countries
136
Brief Summary
This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy versus standard of care (SoC) chemotherapy in participants with pediatric low-grade glioma (LGG) harboring an activating rapidly accelerated fibrosarcoma (RAF) alteration requiring first-line systemic therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Feb 2023
Longer than P75 for phase_3
136 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2022
CompletedFirst Posted
Study publicly available on registry
October 4, 2022
CompletedStudy Start
First participant enrolled
February 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2031
March 2, 2026
February 1, 2026
4.3 years
September 16, 2022
February 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Objective response rate (ORR) of tovorafenib monotherapy versus SoC chemotherapy
ORR assessed per Response Assessment in Pediatric Neuro Oncology (RAPNO) criteria by Independent Review Committee (IRC), and defined as the proportion of participants with overall confirmed response of complete response (CR), partial response (PR), or minor response (MR).
Up to 60 months
Secondary Outcomes (20)
Progression-free survival (PFS) of tovorafenib monotherapy versus SoC chemotherapy
Up to 60 months
Event-free survival (EFS) of tovorafenib monotherapy versus SoC chemotherapy
Up to 60 months
Overall survival (OS) of tovorafenib monotherapy versus SoC chemotherapy
Up to 60 months
Number of participants with any treatment-emergent adverse events, and Serious adverse events
Up to 60 months
. Number of participants with clinically significant vital signs and laboratory abnormalities findings
Up to 60 months
- +15 more secondary outcomes
Study Arms (2)
Tovorafenib
EXPERIMENTALInvestigator's choice of Standard of care therapy
ACTIVE COMPARATORInterventions
Intravenous solution for injection
Eligibility Criteria
You may qualify if:
- Less than 25 years of age with LGG with known activating RAF alteration.
- Histopathologic diagnosis of glioma or glioneuronal tumor.
- At least one measurable lesion as defined by RANO criteria.
- Meet indication for first-line systemic therapy.
You may not qualify if:
- Participant has any of the following tumor-histological findings:
- Schwannoma
- Subependymal giant cell astrocytoma (Tuberous Sclerosis)
- Diffuse intrinsic pontine glioma, even if histologically diagnosed as World Health Organization (WHO) Grade I-II
- Participant's tumor has additional pathogenic molecular alterations, including but not limited to a) isocitrate dehydrogenase (IDH) 1/2 mutation, b) Histone H3 mutation, and c) neurofibromatosis Type 1 (NF-1) loss of function alteration.
- Known or suspected diagnosis of NF-1/ neurofibromatosis Type 2 (NF-2).
- Prior or ongoing nonsurgical anticancer therapy for this indication (eg, chemotherapy, oral/IV targeted therapy) including radiation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (138)
Children's of Alabama
Birmingham, Alabama, 35233, United States
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Children's Hospital of Orange County Main Campus - Orange
Orange, California, 92868, United States
Packard Children's Hospital Stanford
Palo Alto, California, 94304, United States
UCSF Benioff Children's Hospital
San Francisco, California, 94158, United States
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Connecticut Children's Medical Center
Hartford, Connecticut, 06106-3322, United States
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
University of Florida Health
Gainesville, Florida, 32610, United States
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
Arnold Palmer Hospital for Children
Orlando, Florida, 32806, United States
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
University of Chicago
Chicago, Illinois, 60637, United States
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, 46202, United States
University of Iowa Hospitals Clinics
Iowa City, Iowa, 52242, United States
Norton Children's Hospital
Louisville, Kentucky, 40202, United States
Maine Children's Cancer Program
Scarborough, Maine, 04074, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
University of Michigan - - C.S. Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
Children's Minnesota
Minneapolis, Minnesota, 55404, United States
Childrens MS Cncr Ctr Bld Dsr
Jackson, Mississippi, 39216, United States
St. Louis Children's Hospital
St Louis, Missouri, 63110, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198-6878, United States
Albany Medical Center
Albany, New York, 12208, United States
New York University Langone Health
New York, New York, 10016, United States
Columbia University
New York, New York, 10032, United States
University of Rochester
Rochester, New York, 14642, United States
Duke Cancer Institute
Durham, North Carolina, 27705, United States
Cleveland Clinic Main Campus
Cleveland, Ohio, 44195, United States
Oregon Health Science University
Portland, Oregon, 97239, United States
Dell Children's Medical Center of Central Texas
Austin, Texas, 78723, United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Texas Children's Hospital
Houston, Texas, 77030, United States
Seattle Children's Hospital
Seattle, Washington, 98105, United States
University of Wisconsin - Madison
Madison, Wisconsin, 53792, United States
Children's Health Queensland Hospital and Health Service
South Brisbane, Queensland, 4101, Australia
Perth Children's Hospital
Nedlands, 6009, Australia
Women's and Children's Health Network
North Adelaide, 5006, Australia
The Royal Children's Hospital - Children's Cancer Centre
Parkville, 3052, Australia
Sydney Children's Hospital - Randwick
Randwick, 2031, Australia
Children's Hospital at Westmead
Westmead, 2145, Australia
Medizinische Universität Innsbruck
Innsbruck, Tyrol, 6020, Austria
Medizinische Universität Wien
Vienna, 1090, Austria
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, 3000, Belgium
Grupo de Apoio ao Adolescente e à Criança com Câncer (GRAACC)
São Paulo, 04039-001, Brazil
Alberta Children's Hospital
Calgary, Alberta, T3B 6A8, Canada
Stollery Children's Hospital
Edmonton, Alberta, T6G 2B7, Canada
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
McMaster Children's Hospital
Hamilton, Ontario, L8S 4L8, Canada
Children's Hospital London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
CHU Sainte-Justine
Montreal, Quebec, H3T IC5, Canada
The Montreal Children's Hospital
Montreal, Quebec, H4A 3J1, Canada
Centre Hospitalier de l'Université Laval et Centre Mère-Enfant Soleil
Québec, G1V 4G2, Canada
SickKids - The Hospital for Sick Children
Toronto, M5G 1X8, Canada
Fakultní Nemocnice Brno - D?tská Nemocnice
Brno, 625 00, Czechia
Motol University Hospital
Prague, 5 150 06, Czechia
Aarhus Universitetshospital
Aarhus, Central Jutland, 8200, Denmark
Rigshospitalet
Copenhagen, 2100, Denmark
CCHE
Cairo, Cairo Governorate, 11441, Egypt
Helsingin yliopistollinen sairaala (HUS)
Helsinki, FI-00290, Finland
Tampereen Yliopistollinen Sairaala
Tampere, 33520, Finland
Centre de Lutte contre le Cancer - Centre Oscar Lambret
Lille, 59020, France
Centre Léon Bérard
Lyon, 69008, France
Hôpital de la Timone
Marseille, 13005, France
Institut Curie
Paris, 75248, France
Gustave Roussy
Villejuif, 94805, France
Universitätsklinikum Freiburg
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
Universitätsklinikum Augsburg
Augsburg, Bavaria, 86156, Germany
Universitätsklinikum Erlangen
Erlangen, Bavaria, 91054, Germany
Universitätsklinikum Würzburg
Würzburg, Bavaria, 97080, Germany
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, 60590, Germany
Medizinische Hochschule Hannover
Hanover, Lower Saxony, 30625, Germany
Universitaetsklinikum Essen
Essen, North Rhine-Westphalia, 45147, Germany
Universitätsklinikum Leipzig
Leipzig, Saxony, 4103, Germany
Charité Universitätsmedizin Berlin
Berlin, 13353, Germany
Evangelische Klinikum Bethel (EvKB)
Bielefeld, 33617, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
Universitätsklinikum Tübingen
Tübingen, 72076, Germany
Aghia Sofia General Children's Hospital
Athens, 11527, Greece
Athens General Children's Hospital
Athens, 11527, Greece
Semmelweis Egyetem Tűzoltó utcai II. Sz. Gyermekgyógyászati Kliniká
Budapest, 1094, Hungary
Children's Health Ireland at Crumlin
Crumlin, Dublin, D12 N512, Ireland
Schneider Children's Medical Center of Israel
Petah Tikva, 49202, Israel
The Edmond and Lily Safra Children's Hospital
Ramat Gan, 5265601, Israel
Fondazione IRCCS - Istituto Nazionale dei Tumori
Milan, Milan, 20133, Italy
Ospedale Pediatrico Bambino Gesù
Roma, Rome, 00165, Italy
Ospedale Infantile Regina Margherita
Torino, Turin, 10126, Italy
Azienda Universitaria Ospedaliera Consorziale - Policlinico di Bari
Bari, 70124, Italy
Azienda Ospedaliera U. Meyer
Florence, 50139, Italy
Istituto Giannina Gaslini
Genova, 16147, Italy
Azienda Ospedaliera di Rilievo Nazional Santobono Pausilipon
Naples, 80131, Italy
Azienda Ospedale Università di Padova
Padua, 35128, Italy
Azienda Sanitaria Universitaria Friuli Centrale - P.O. Santa Maria della Misericordia
Udine, 33100, Italy
King Hussein Cancer Foundation - King Hussein Cancer Center
Amman, Muhafazat al-Asima, 11941, Jordan
Prinses Maxima Centrum Kinderoncologie
Utrecht, 3584 CS, Netherlands
Starship Paediatric Blood & Cancer Center
Grafton, 1023, New Zealand
Universitetssykehuset Nord-Norge - Tromsø
Tromsø, Troms, 9038, Norway
Oslo Universitetssykehus
Oslo, 372, Norway
Sidra Medicine
Doha, 26999, Qatar
SingHealth Group - KK Women's and Children's Hospital
Singapore, 229899, Singapore
Univerzitetni Klinini Center Ljubljana
Ljubljana, 1000, Slovenia
Seoul National University Hospital
Seoul, 03080, South Korea
Severance Hospital
Seoul, 03722, South Korea
Hospital Universitario Cruces
Barakaldo, 48903, Spain
Hospital Universitari Vall d'Hebrón
Barcelona, 08035, Spain
Hospital Sant Joan de Déu Barcelona
Barcelona, 08950, Spain
Hospital Infantil Universitario Niño Jesús
Madrid, 28009, Spain
Hospital Universitario La Paz
Madrid, 28046, Spain
Hospital Universitario Virgen del Rocío
Seville, 41013, Spain
Hospital Universitari i Politècnic La Fe
Valencia, 46026, Spain
Drottning Silvias barn- och ungdomssjukhus
Gothenburg, 416 85, Sweden
Skånes Universitetssjukhus - Lund
Lund, 221 85, Sweden
Astrid Lindgrens Barnsjukhus Solna
Stockholm, 171 77, Sweden
Centre Hospitalier Universitaire Vaudois Lausanne
Lausanne, 1011, Switzerland
Universitaets - Kinderspital Zürich
Zurich, 8032, Switzerland
Taipei Medical University Hospital
Taipei, 110, Taiwan
Chang Gung Memorial Hospital - Linkou Branch
Taoyuan District, 333, Taiwan
Birmingham Women's and Children's NHS Foundation Trust
Birmingham, England, B4 6NH, United Kingdom
Leeds Teaching Hospital NHS Trust
Leeds, England, LS1 3EX, United Kingdom
Alder Hey Children's NHS Foundation Trust
Liverpool, England, L12 2AP, United Kingdom
Manchester University NHS Foundation Trust
Manchester, England, M13 PWL, United Kingdom
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, England, NE1 4LP, United Kingdom
Great Ormond Street Hospital for Children
Oxford, England, WC1N 3JH, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, SO16 6YD, United Kingdom
Royal Belfast Hospital for Sick Children
Belfast, Northern Ireland, BT9 7AB, United Kingdom
NHS Greater Glasgow and Clyde
Glasgow, Scotland, G51 4TF, United Kingdom
Sheffield Children's Hospital
Sheffield, South Yorkshire, S10 2TH, United Kingdom
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, SM2 5PT, United Kingdom
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, BS2 8HW, United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ, United Kingdom
The Christie Hospital
Manchester, M20 4BX, United Kingdom
Related Publications (1)
van Tilburg CM, Kilburn LB, Perreault S, Schmidt R, Azizi AA, Cruz-Martinez O, Zapotocky M, Scheinemann K, Meeteren AYNS, Sehested A, Opocher E, Driever PH, Avula S, Ziegler DS, Capper D, Koch A, Sahm F, Qiu J, Tsao LP, Blackman SC, Manley P, Milde T, Witt R, Jones DTW, Hargrave D, Witt O. LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration. BMC Cancer. 2024 Jan 30;24(1):147. doi: 10.1186/s12885-024-11820-x.
PMID: 38291372DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2022
First Posted
October 4, 2022
Study Start
February 27, 2023
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2031
Last Updated
March 2, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share